美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
63629-2390-1	63629-2390	HUMAN PRESCRIPTION DRUG	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20210222	N/A	ANDA	ANDA204071	Bryant Ranch Prepack	SODIUM POLYSTYRENE SULFONATE	4.1 meq/g	454 g in 1 JAR (63629-2390-1)
63629-8849-1	63629-8849	HUMAN PRESCRIPTION DRUG	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20210920	N/A	ANDA	ANDA204071	Bryant Ranch Prepack	SODIUM POLYSTYRENE SULFONATE	4.1 meq/g	15 g in 1 BOTTLE (63629-8849-1)
63629-8850-1	63629-8850	HUMAN PRESCRIPTION DRUG	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20210920	N/A	ANDA	ANDA204071	Bryant Ranch Prepack	SODIUM POLYSTYRENE SULFONATE	4.1 meq/g	15 g in 1 BOTTLE (63629-8850-1)
72162-1230-2	72162-1230	HUMAN PRESCRIPTION DRUG	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20230913	N/A	ANDA	ANDA204071	Bryant Ranch Prepack	SODIUM POLYSTYRENE SULFONATE	4.1 meq/g	454 g in 1 JAR (72162-1230-2)
11534-166-44	11534-166	HUMAN PRESCRIPTION DRUG	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20170124	N/A	ANDA	ANDA204071	SUNRISE PHARMACEUTICAL, INC.	SODIUM POLYSTYRENE SULFONATE	4.1 meq/g	454 g in 1 JAR (11534-166-44)
11534-166-16	11534-166	HUMAN PRESCRIPTION DRUG	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20170124	N/A	ANDA	ANDA204071	SUNRISE PHARMACEUTICAL, INC.	SODIUM POLYSTYRENE SULFONATE	4.1 meq/g	15 g in 1 BOTTLE (11534-166-16)
11534-166-15	11534-166	HUMAN PRESCRIPTION DRUG	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20170124	N/A	ANDA	ANDA204071	SUNRISE PHARMACEUTICAL, INC.	SODIUM POLYSTYRENE SULFONATE	4.1 meq/g	15 g in 1 BOTTLE (11534-166-15)
10135-146-17	10135-146	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate	sodium polystyrene sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20160301	N/A	ANDA	ANDA204071	Marlex Pharmaceuticals Inc	SODIUM POLYSTYRENE SULFONATE	4.1 meq/g	454 g in 1 JAR (10135-146-17)
10135-146-14	10135-146	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate	sodium polystyrene sulfonate	POWDER, FOR SUSPENSION	ORAL; RECTAL	20160301	N/A	ANDA	ANDA204071	Marlex Pharmaceuticals Inc	SODIUM POLYSTYRENE SULFONATE	4.1 meq/g	15 g in 1 BOTTLE, PLASTIC (10135-146-14)